Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Total Current Liabilities (2016 - 2025)

Skinvisible's Total Current Liabilities history spans 16 years, with the latest figure at $4.8 million for Q3 2025.

  • For Q3 2025, Total Current Liabilities rose 2.63% year-over-year to $4.8 million; the TTM value through Sep 2025 reached $4.8 million, up 2.63%, while the annual FY2024 figure was $3.7 million, 4.12% up from the prior year.
  • Total Current Liabilities for Q3 2025 was $4.8 million at Skinvisible, up from $4.5 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $4.8 million in Q3 2025 and bottomed at $2.7 million in Q1 2023.
  • The 5-year median for Total Current Liabilities is $3.5 million (2023), against an average of $3.6 million.
  • The largest annual shift saw Total Current Liabilities decreased 12.62% in 2023 before it soared 50.18% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $3.1 million in 2021, then grew by 19.07% to $3.6 million in 2022, then decreased by 3.64% to $3.5 million in 2023, then rose by 4.12% to $3.7 million in 2024, then soared by 30.31% to $4.8 million in 2025.
  • Per Business Quant, the three most recent readings for SKVI's Total Current Liabilities are $4.8 million (Q3 2025), $4.5 million (Q2 2025), and $4.3 million (Q1 2025).